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source of nitric oxide in the human kidney under physiologicExpression of NOS1 and soluble guanylyl cyclase by human
conditions.kidney epithelial cells: Morphological evidence for an auto-
crine/paracrine action of nitric oxide.
Background. Nitric oxide plays an important role in the
kidney through effects on both renal hemodynamics and tubu-
Nitric oxide is an inter- and intracellular mediator withlar functions. Tubular epithelial cells are thus a target for nitric
diverse physiologic actions, that is synthesized as a by-oxide. However, as to whether tubular epithelial cells endogen-
eously produce nitric oxide under physiologic conditions in product originating from the conversion of l-arginine to
human kidney is currently unknown. The aim of the present l-citrulline, in a reaction catalyzed by nitric oxide syn-
study was to characterize and localize in situ the nitric oxide thases (NOS) [1]. Three isoforms of NOS exhibiting dif-synthase (NOS) isoforms (NOS1, NOS2, and NOS3) expressed
ferent distribution and biochemical properties have beenin human normal kidney, and soluble guanylyl cyclase, the
identified in mammal tissues: neuronal (nNOS, NOS1),well-known target for nitric oxide.
Methods. Five complementary experimental approaches were endothelial (eNOS, NOS3), and inducible (iNOS, NOS2)
used: (1) detection of NOS reductase activity by nicotinamide [2, 3]. Constitutive forms of NOS (NOS1 and NOS3) are
adenine dinucleotide phosphate (NADPH)-diaphorase histo- strictly Ca-dependent and generate small amounts ofchemistry, (2) immunolocalization of the NOS isoforms (NOS1,
nitric oxide, which are generally believed as responsibleNOS2, NOS3), (3) immunoblot analysis, (4) quantitative re-
verse transcription-polymerase chain reaction (RT-PCR) anal- for modulating the physiologic function of cells. On the
ysis of NOS mRNA, and (5) measurement of NOS activity as contrary, the Ca-independent iNOS (NOS2) requires
the conversion rate of l-[14C]-arginine to l-[14C]-citrulline. In several hours for induction, and generates high amounts
addition, in situ detection of soluble guanylyl cyclase was as-
of nitric oxide. The reactive nitrogen oxide species re-sessed by immunohistochemistry.
sulting from these high nitric oxide concentrations canResults. All these techniques led to consistent results show-
ing that epithelial cells of most tubules along the human neph- lead to cell injury [4]. However, the distinction between
ron exhibit functional NOS1, with a corticomedullary gradient constitutive and inducible NOS has recently appeared
observed both at the protein and mRNA levels. Moreover, not so clear-cut. Indeed, it has been shown that each ofepithelial cells expressing NOS1 also express soluble guanylyl
the three isoforms can be constitutively expressed incyclase, indicating that these cells possess the machinery for
different cell types or be induced by various stimuli. Theautocrine/paracrine effect of nitric oxide.
Conclusion. The present study demonstrates that NOS1 is three NOS isoforms can be expressed in a variety of
strongly expressed in most tubules of the human nephron and cells and tissues different from those in which they were
therefore invites to consider epithelial cells as one of the major
initially characterized and cloned [3]. In addition, tissue-
specific variants have been described for NOS1 [5–7].
1 Dr. Jarry and Dr. Renaudin contributed equally to this work. Nitric oxide is well known to have potent influence
on kidney function [8] through effects on renin secretionKey words: nitric oxide synthase, human kidney, tubular epithelial
cells, soluble guanylyl cyclase. [9], glomerular hemodynamics [10], and medullary blood
flow [11]. It was also demonstrated to increase natriuresisReceived for publication March 28, 2002
without affecting the rate of glomerular filtration. Ac-and in revised form November 29, 2002
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segments of the nephron. In this respect, nitric oxide tissue was taken at some distance from the tumor. These
was, for instance, shown to inhibit the activity of Na,K- samples could be used, according to the French guide-
ATPase and Na/H exchanger in proximal tubule [12, 13] lines, since they are considered as residual tissues not
and to stimulate K channel in thick ascending limb [14]. relevant to diagnosis. For each case, the cortex, outer
An increasing number of investigations in animal models medulla, and inner medulla were dissected, snap-frozen,
and to a lesser degree in humans indicate that nitric oxide and stored in liquid nitrogen. Normal renal parenchyma
plays also an important role in renal pathophysiology. In was also fixed in 10% formalin and embedded in paraffin.
support to this view, high amounts of NOS2-derived For each case, a histologic examination of the normal
nitric oxide are involved in the evolution of glomerulone- kidney was done before performing the experiments.
phritis and tubulointerstitial injury in postischemic renal Only samples displaying normal glomeruli and tubules
failure [15, 16], or in acute and chronic allograft rejection and without any inflammatory infiltrate were selected.
[17]. NOS1-derived nitric oxide appears to have a key A case of inflammatory bowel disease (ulcerative colitis)
role in the pathogenesis of renal hemodynamic changes was used as a positive control for NOS2.
in diabetes [18]. Conversely, a decrease in intrarenal
production of nitric oxide was reported in animal models NADPH-diaphorase histochemistry
of subtotal renal ablation, ureteral obstruction and dia-
Five micrometer cryostat sections were fixed for 15betes, and administration of l-arginine was shown to
minutes in a freshly made paraformaldehyde solutionretard deterioration of kidney function [19–22]. Thus,
[4% wt/vol in phosphate-buffered saline (PBS)] and thencertainly due to its dual effects as a cytoprotective or
washed four times in PBS. The NADPH-diaphorase ac-deleterious agent, the role of nitric oxide in renal pathol-
tivity of NOS, which is paraformaldehyde-resistant, wasogy remains unclear and controversial.
demonstrated by enzymatic reduction of nitro blue tetra-Despite the numerous physiologic approaches aiming
zolium in the presence of NADPH, as previously de-to establish the role of nitric oxide in renal functions,
scribed [26]. Briefly, slides were incubated in 1  PBSmain studies have been performed in rodents, and human
containing 1 mg/mL NADPH (Roche, Meylan, France)kidney still remains an organ in which the cellular sources
and 0.4 mg/mL nitro blue tetrazolium (Roche) for 30of nitric oxide as well as the isoforms of NOS involved
minutes at 37C, washed in PBS, dehydrated, and mountedhave not been fully investigated [16, 17, 23–25].
without any counterstaining. NADPH was omitted inThe aim of the present study was to characterize and
negative controls.localize in situ the NOS isoforms, NOS1, NOS2 and
NOS3, expressed in normal human kidney. The expres-
Immunohistochemical stainingsion of NOS was assessed using different approaches,
including in situ localization of the nicotinamide adenine Immunohistochemistry was performed on 5 m for-
dinucleotide phosphate (NADPH)-diaphorase activity malin-fixed paraffin sections of normal renal paren-
of NOS, immunolocalization of NOS isoforms on sec- chyma for staining with the C-term NOS1 and the soluble
tions of renal parenchyma, immunoblot analysis, detec- guanylyl cyclase antibodies, and on 5 m acetone-fixed
tion of mRNAs, and determination of NOS activity as cryostat sections for staining with all other antibodies
the conversion rate of l-arginine to l-citrulline. In our (Table 1). First, endogenous biotin was blocked using a
hands, this panel of techniques gave consistent results, sequential avidin-biotin treatment (Dako Biotin Block-
leading to the conclusion that, besides the expected ing System, Dako, Trappes, France). Then, immunohis-
NOS3 expressing endothelial cells, epithelial cells of tochemistry was performed using a streptavidin-biotin
most of the renal tubules expressed a functional constitu- method (Histostain Plus Kit, LAB-SA Detection Sys-
tive NOS of the NOS1 isotype with a corticomedullary tem, Zymed, Clinisciences, Montrouge, France), ac-
gradient observed both at the protein and mRNA levels. cording to the manufacturer’s instructions. The specific-
In addition, human normal renal kidney did not display ity and conditions of use of the primary antibodies
NOS2 isoform. Thus, together with endothelial cells, epi-
directed to NOS isoforms or soluble guanylyl cyclase are
thelial cells constitute one of the major sources of nitric
listed in Table 1. Aminoethyl carbazol (AEC) was usedoxide in the human kidney under physiologic conditions.
as a chromogen. The sections were slightly counterstainedAccording to our data, epithelial cells expressing NOS1
with hematoxylin and mounted in glycergel (Dako). Ad-also contain soluble guanylyl cyclase, which allows an
equate negative controls were performed by omittingautocrine/paracrine effect of nitric oxide.
the first antibody or using irrelevant antibodies of the
same immunoglobulin (Ig) isotype. Immunohistochemi-
METHODS cal staining was assessed by two independent observers
Tissue specimens (A.J. and K.R.), including a pathologist (K.R.). The
staining was evaluated as (1) no staining (); (2) positiveNormal human renal tissue was collected from 12 pa-
tients undergoing nephrectomy for renal tumor. Normal staining (); and (3) heterogeneous staining (*) be-
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Table 1. Antibodies used for the detection of nitric oxide synthase (NOS) isoforms and of soluble guanylyl cyclase (sGC) by
immunohistochemistry and immunoblot analysis
Protein Type of Antigen (amino acids) Immunohistochemistry: frozen (F),
detected antibody source C- or NH2-terminus paraffin (P)/dilution Immunoblot/dilution
NOS1 Monoclonal Synthetic human peptide Immunohistochemistry (F)/1:100
Transduction Lab C-terminus (1095–1289) Immunoblot/1:2500
NOS1 Polyclonal Rat recombinant protein Immunohistochemistry (P)/1:200
Zymed NH2-terminus (last 200 aa)
NOS2 Polyclonal Synthetic human peptide Immunohistochemistry (F)/1:500
Santa Cruz C-terminus Immunoblot/1:500
NOS3 Polyclonal Synthetic human peptide Immunohistochemistry (F)/1:300
Santa Cruz C-terminus
NOS3 Polyclonal Synthetic human peptide Immunohistochemistry (F)/1:300
Transduction Lab C-terminus Immunoblot/1:500
sGC Polyclonal Synthetic human peptide Immunohistochemistry [(F)/1:800; (P)/1:200]
Cayman from 1 and 1 subunits
tween tubules of the same type (distal tubules) or among mia virus (M-MLV) reverse transcriptase (200 units)].
The amplification conditions of the NOS1 and GAPDHthe various cell types of a given tubule (collecting duct).
templates were optimized for the LightCycler instru-
Immunoblot analysis ment. PCR amplifications were performed using the Fast-
Start DNA Master SYBR Green I (Roche MolecularTotal proteins were extracted from the 12 specimens
of normal kidney (cortex, outer medulla, and inner me- Biochemicals) Real-Time PCR kit. The PCR primers were
chosen on separate exons to amplify cDNA but not geno-dulla) using the Tri-Reagent (Euromedex, Mundols-
heim, France) [27] according to the manufacturer’s in- mic DNA. The following primers were used: 5-TCTC
CTCCTACTCTGACTCC-3 (NOS1 sense) and 5-TTGstructions. Fifty micrograms of protein were separated by
7.5% SDS-PAGE in reducing conditions and transferred TGGACATTGGATAGACC-3 (NOS1 antisense); and
5-TGAACGGGAAGCTCACTGG-3 (GAPDH sense)onto nitrocellulose membrane (BioRad, Marnes La Co-
quette, France). The membranes were treated for 1 hour and 5-TCCACCACCCTGTTGCTGTA 3(GAPDH
antisense). Primers (0.4 mol/L each) and additionalat room temperature or overnight at 4C with 1%
blocking reagent (Roche), incubated for 1 hour at room MgCl2 (final concentration 4 mmol/L) were combined
with 2 L FastStart reaction mixture and PCR gradetemperature with the appropriate NOS antibody diluted
in Tris-buffered saline (TBS)/0.5% blocking solution, water up to a volume of 18 L. The glass capillary reac-
tion tubes of the LightCycler were loaded with 18 Lwashed several times in TBS/0.1% Tween, incubated for
45 minutes at room temperature with a rabbit anti-mouse of this master mix and 2 L of the template (cDNA
diluted 1/100). The cycling conditions were as follows:antibody conjugated to horseradish peroxidase (Santa
Cruz Biotechnology, Tebu, Le Perray en Yvelines, France), denaturation for 5 minutes at 95C; amplification for 40
cycles, with denaturation for 0 seconds at 95C, annealing1:1000 dilution in TBS/0.5% blocking reagent and washed
in TBS/Tween. The immunoreactive proteins were then for 10 seconds at 62C, and extension for 15 seconds at
72C. The emitted fluorescence was measured at the enddetected by chemiluminescence [BM Chemiluminescence
Blotting Substrate (POD), Roche]. Lysates of rat brain of each cycle. After completion of the cycling process,
samples were subjected to a temperature ramp (fromfor NOS1, ulcerative colitis for NOS2, and human en-
dothelial cells for NOS3 (Transduction Lab, BD Bio- 64C to 95C) with continuous fluorescence monitoring
for melting curve analysis. For each PCR product, asciences, Le Pont de Claix, France) served as positive
controls. single narrow peak was obtained at the specific melting
temperature, indicating specific amplification. A stan-
Quantitative RT-PCR analysis of NOS1 dard curve was generated with serial fourfold dilutions
of cDNA (1:10, 1:40, 1:160, and 1:640), prepared fromTotal RNAs from three specimens of normal kidney
(cortex and inner medulla) were isolated using the Tri- normal kidney RNA. All standards and samples were
tested in duplicate and the average value of both dupli-Reagent kit (Euromedex) [27]. RNA (5 g) was dena-
turated at 72C for 3 minutes and then reverse tran- cates was used for quantification. The amount of NOS1
or GAPDH transcript was calculated from the standardscribed for 60 minutes at 42C in a 20L reaction volume
[50 mmol/L Tris-HCl, pH 8.3, 75 mmol/L KCl, 3 mmol/L curves using the LightCycler software. It was expressed
in relative units, one relative unit corresponding to 1:640MgCl2, 10 mmol/L dithiothreitol (DTT) containing 0.5 g
of random hexamers (Promega, Charbonnie`res, France), dilution of the standard. For each sample, the ratio be-
tween the relative amount of NOS1 and GAPDH wasdesoxynucleoside triphosphate (dNTP) (1 mmol/L each),
RNasin (50 units) and RnaseH Moloney-murine leuke- calculated to compensate for variations in quantity or
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quality of starting mRNA as well as for differences in In situ detection of NOS reductase activity by
reverse transcriptase efficiency. NADPH-diaphorase histochemistry
The results of the histochemical detection of NOSNOS activity measurement
activity by NADPH-diaphorase reaction performed on
NOS activity was measured by the conversion of l-[14C]- paraformaldehyde-fixed cryostat sections are summa-
arginine to l-[14C]-citrulline, in the presence of ornithine rized in Table 2. As shown in Figure 1, NADPH-diapho-
(1.5 mmol/L) in order to inhibit arginase activity [28, 29]. rase activity was predominant in renal tubules, with a
Briefly, cortex or inner medulla of three human normal more pronounced staining pattern in cortex and outer
renal kidney were homogenized on ice in a cold buffer medulla than in inner medulla. In the cortex, glomeruli
containing 50 mmol/L Tris-HCl, pH 7.4, 0.1 mmol/L ethyl- displayed a weak NADPH-diaphorase activity located
enediaminetetraacetic acid (EDTA), 0.1 mmol/L ethyl- in capillaries endothelial cells and in some podocytes.
eneglycol tetraacetate (EGTA), with 5 g/mL leupeptin, Mesangial cells and parietal cells of Bowman’s capsule
5 g/mL aprotinin, and 0.1 mmol/L Pefabloc. Homogen- appeared negative. Concerning tubules, epithelial cells
eates were centrifuged at 105,000 g during 1 hour and of the proximal tubules showed a strong NADPH-diaph-
NOS activity was measured in the supernatants and in orase activity. Those of distal tubules were also positive;
the pellets solubilized in Tris-HCl buffer. An aliquot however, staining was heterogeneous from one tubule to
(25 L) was mixed to 100 L of incubation buffer con- another. When the juxtaglomerular apparatus was visible,
taining 50 mmol/L Tris-HCl, pH 7.4, 3 mmol/L NADPH, macula densa was strongly positive and endothelial cells
75 mol/L CaCl2, 100 nmol/L calmodulin, 4 mol/L fla- of arterioles were faintly labeled. Collecting ducts in the
vin adenine dinucleotide (FAD), 4 mol/L flavin mono- cortex and medulla displayed a moderate NADPH-diapho-
nucleotide (FMN), 6 mol/L BH4, 10 mol/L l-[14C]- rase activity. In the outer medulla, NADPH-diaphorase
arginine monohydrochloride (313 mCi/mmol, NEN, Paris, activity predominated in the medullary thick ascending
France), and incubated 10 mn at 37C. Stop reaction was limb of Henle’s loops, whereas the thin limbs of Henle’s
promoted by addition of 1 mL of 50 mmol/L HEPES loops appeared faintly stained or even negative. The
buffer containing 5 mmol/L EDTA, pH 5.5, and 0.5 mL inner medulla displayed a weak NADPH-diaphorase ac-
of resin suspension (Dowex 5OWX8-400, Sigma-Aldrich,
tivity, mainly encountered in collecting ducts and almost
St. Quentin-Fallavier, France), in order to absorb the
absent in thin limbs of Henle’s loops. A weak NADPH-
l-[14C]-arginine nontransformed into l-[14C]-citrulline.
diaphorase reaction was also observed in endothelial
An aliquot of the supernatant was then counted in a liquid
cells of arterioles, capillaries, and vessels in the cortex
scintillation analyzer (Packard Tricarb 2100 TR). Each
and medulla. Some nerve fibers and perivascular nervepreparation was tested in duplicate in the presence and
bundles were positively marked all along the kidney,absence of NADPH to establish the NADPH-dependent
especially in the inner medulla and hilar region. All thesecitrulline formation, or in the presence and absence of dif-
structures scored positive as early as after 5 to 10 min-ferent inhibitors (100 mol/L): l-arginine analog N-nitro-
utes’ incubation and no reaction product was observedl-arginine methyl ester (L-NAME) and NG-monomethyl-
when NADPH was omitted.l-arginine (L-NMMA), inhibitors of all NOS isoforms,
S-methyl-l-thiocitrulline (SMTC) (Cayman, Spibio, Massy, Characterization of the NOS isoforms by
France), a selective NOS1 inhibitor. The constitutive immunohistochemistry and immunoblot analysis
NOS activity was measured in the presence of 1 mmol/L
The NADPH-diaphorase activity detected in most tu-EGTA in a buffer devoid of Ca and calmodulin.
bular epithelial cells suggests that these cells are an im-NADPH-dependent activity, NOS activity, or Ca-
portant source of nitric oxide in the kidney. We thendependent activity were determined by substracting total
further characterized the NOS isoforms in epithelial andcounts from counts remaining in the absence of NADPH,
endothelial cells by immunohistochemistry using specificor in the presence of inhibitors or of the Ca-chelator
antibodies directed to NOS1, NOS2, and NOS3. In eachEGTA. NOS activity was expressed as picomole per milli-
experiment, negative controls were performed (i.e., bygram protein per minute (pmol/mg/min).
omitting the primary antibody and by using irrelevant
antibodies of the same Ig isotype instead of the primary
RESULTS specific antibodies) and staining was always absent.
The “inducible” form of NOS, NOS2, was not detectedIdentification and localization of the different isoforms
in normal human kidney. Indeed, it was never found inof NOS (i.e., NOS1, NOS2, NOS3) were assessed in
glomeruli or in the various tubules of the cortex andseveral samples (6 to 12) of normal human renal paren-
medulla (Table 2 and Fig. 2A). A positive control forchyma (cortex, outer medulla, and inner medulla), at
NOS2 was used (i.e., colonic mucosa from a case ofboth protein and mRNA levels using five complementary
methods. ulcerative colitis, known to contain high levels of NOS2
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Table 2. Localization of nitric oxide synthase (NOS) and soluble guanylyl cyclase (sGC) in normal human kidney
Detection of NOS and sGC by immunohistochemistry
NADPH-diaphorase NOS1 NOS3 NOS2 sGC
Intrarenal distribution activity (N 	 12) (N 	 12) (N 	 6) (N 	 6) (N 	 10)
Glomeruli
Mesangial cells     
Podocytes * *   *
Parietal cells     *
Cortical tubules
Macula densa     
Proximal tubules     
Distal tubules * *   
Collecting ducts * *   
Medullary tubules
Thick ascendant limb HL     
Thin limbs HL     
Collecting ducts * *   
Endothelium     
NADPH is nicotinamide adenine dinucleotide phosphate; HL is Henle’s loop.
NADPH-diaphorase reaction and immunohistochemical detection of NOS and sGC were performed on cryostat or paraffin sections of histologically normal human
kidney (cortex, outer, and inner medulla for each case), as described in the Methods section.
, positive staining; , no staining; *, heterogenous staining.
in the epithelium) [30] (Fig. 2B). Immunoblot analysis calization and distribution of NOS1 were similar from
one kidney to another.confirmed the absence of the 130 kD form of NOS2 in
normal human kidney (Fig. 2C). To further verify that NOS reactivity detected in renal
epithelial cells by immunohistochemistry truly corre-Concerning the “constitutive” isoforms of NOS, we
assessed the expression of the neuronal form NOS1 and sponded to NOS1, immunoblots were performed on
crude tissue extracts from the main regions of renal pa-of the endothelial form NOS3.
Given the strong homologies between the C-terminus renchyma (cortex, outer medulla, and inner medulla)
with the anti-NOS1 antibody. As shown in Figure 3B,part of NOS1 with other proteins having a NADPH
reductase activity [3, 26], the expression of NOS1 was which illustrates the results obtained on three represen-
tative samples, a band of 155 kD was observed. Theassessed by using the monoclonal antibody derived from
a peptide mapping at the carboxy terminus of the NOS1 intensity of the 155 kD band, although variable from
one kidney to another, was far higher in the cortex and(NOS1-C) and another polyclonal antibody directed to
the N-terminus of NOS1 (NOS1-N). In addition, this outer medulla than in the inner medulla, in which it was
in most cases hardly detectable.antibody is suitable for paraffin-embedded sections, thus
allowing a better characterization of the tubules and of NOS3 was expressed in capillary endothelial cells of
the glomeruli and in the endothelium of cortical andtheir cellular components along the nephron. The overall
staining pattern was identical with both antibodies and medullar vessels, as expected. However, NOS3 was never
detected in other cell types of the glomeruli and in tubu-showed that NOS 1 was expressed in tubular epithelial
cells all along the nephron (Fig. 3A and Table 2). A lar epithelial cells (Fig. 4A and Table 2). Immunoblot
analysis confirmed the expression of the 155 kD form ofhigher proportion of tubules scored positive for NOS1
in the cortex and outer medulla than in the inner medulla. NOS3 (Fig. 4B).
Altogether, these findings demonstrate that the consti-In the cortex, proximal tubules and macula densa were
strongly stained; distal tubules displayed a heterogenous tutive NOS of the NOS1 isotype is expressed by epithe-
lial tubular cells in normal human kidney. Expression isstaining from one tubule to another. Cortical and medul-
lary collecting duct showed a strong reinforced immuno- moreover heterogeneous, with a gradient of expression
(i.e., cortex/outer medulla 
 inner medulla). NOS3 wasreactivity in the large and round-shaped cells with mor-
phologic characteristics of intercalated cells scattered present only in endothelial cells of cortical and medullar
blood vessels. Moreover, NOS2 was not expressed inwithin the tubule, whereas principal cells, representing
normal human renal parenchyma.the majority of collecting duct cells, displayed a weaker
labeling. Concerning Henle’s loops, the thick ascending
Measurement of NOS1 mRNA levels by quantitativelimb was strongly stained while the thin limb was hetero-
RT-PCR analysisgeneously and very weakly stained. In glomeruli, only
some podocytes expressed NOS1. Although the staining In order to assess whether the corticomedullary gradi-
ent of NOS1 expression was a reflection of its mRNAintensity could vary, it is to be noted that the immunolo-
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Fig. 2. Analysis of nitric oxide synthase (NOS) NOS2 isoform in nor-
mal human kidney. NOS2 was not detected in the cortex of human
Fig. 1. Localization of nicotinamide adenine dinucleotide phosphate normal kidney, either by immunohistochemistry on cryostat sections
(NADPH)-diaphorase activity in normal human renal parenchyma. (A ) (original magnification 200), or using immunoblot analysis (C )
Assessment of NADPH-diaphorase activity was performed on para- (lanes 2, 3, and 4 correspond to three samples of cortex). Immunoblot
formaldehyde-fixed cryostat sections as described in the Methods sec- analysis was performed as described in the Methods section. Numbers
tion. The nitro blue tetrazolium precipitate is highly detectable in tu- on the left indicate molecular size of standards in kD. A case of ulcera-
bules, with a more pronounced staining pattern in cortex (A ) and outer tive colitis, strongly expressing NOS2 in the epithelium, was used as a
medulla (B ) than in inner medulla (C ). A weak NADPH-diaphorase positive control for immunohistochemistry (B ) (original magnification
activity is present in capillaries endothelial cells and in some podocytes. 200) and immunoblot analysis (C) (lane 1).
Original magnification 200.
of NOS1 transcripts were normalized to -actin as alevel, the amount of NOS1 mRNA was measured by
reference gene.quantitative RT-PCR. Analysis of RNA extracted from
three kidneys indicated a higher amount of NOS1 ampli-
Measurement of a functional NOS activityfication product normalized to GAPDH in the cortex
NOS activity was measured as the conversion of l-[14C]-than in the inner medulla (Fig. 5). As for immunoblot
arginine into l-[14C]-citrulline, in the cytosolic and pelletexperiments, the amount of NOS1 amplification product
fractions of both cortex and inner medulla of three kid-as well as the value of the cortex/medulla ratio varied
ney samples. According to the literature, Ca-depen-from one sample to another. The corticomedullary gradi-
ent of NOS1 expression was also observed when levels dent NOS activity detected in the cytosolic fraction re-
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Fig. 3. Localization of nitric oxide synthase (NOS1) isoform in the normal human kidney. (A ) Immunohistochemical detection of NOS1 in paraffin
sections using a polyclonal antibody directed to the N-terminus of NOS1 (left to right: cortex, outer medulla, inner medulla). The cortex showed
NOS1 immunoreactivity in the proximal and distal tubules, including the macula densa (MD). In outer medulla, thick ascending limb of Henle’s
loops strongly expressed NOS1, while thin limbs in the outer and inner medulla did not express NOS1. Medullary collecting ducts expressed
NOS1, with a stronger expression in cells with the morphological characteristics of intercalated cells (*) (original magnification 200). (B )
Immunoblot analysis of NOS1 expression in the cortex, outer medulla, and inner medulla of three samples of human normal kidney. A cortex/
inner medulla gradient of NOS1 protein expression was observed. Immunoblot was performed as described in the Methods section. Numbers on
the left indicate molecular size of standards in kD.
flects the NOS1 activity, whereas the one detected in the
pellet fraction reflects both membrane-bound NOS1 and
NOS3 [31, 32]. As in the kidney, other metabolic path-
ways than NOS can lead to l-[14C]-citrulline formation
from l-[14C]-arginine, we measured total l-[14C]-citrulline
formation as well as NADPH-, L-NAME-, L-NMMA-,
SMTC-dependent l-[14C]-citrulline formation. Figure 6
shows that in the cortex or medulla cytosolic fractions,
the NADPH-dependent l-[14C]-citrulline formation and
the L-NAME-, L-NMMA-, SMTC-dependent l-[14C]-
citrulline formation were very similar. These results
strongly suggest that the l-[14C]-citrulline formation mea-
sured in these conditions was due to NOS activity. This
NOS activity represented 45% and 60% of total l-[14C]-
citrulline formation in the cortex and medulla cytosolic
Fig. 4. Analysis of nitric oxide synthase (NOS3) isoform in the human
normal kidney. (A ) Immunohistochemical detection of NOS3 in cryo-
stat sections of cortex. NOS3 was detected only in endothelial cells of
glomeruli capillaries, and of the blood vessels present in the cortex.
NOS3 was not detected in the tubular epithelial cells (original magnifi-
cation 200). (B ) Immunoblot analysis of NOS3 expression in the
cortex of three kidney samples (lanes 1, 2, and 3). Immunoblot was
performed as described in the Methods section. Numbers on the left
indicate molecular size of standards in kD.
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including thin limbs of Henle’s loops, which displayed a
very faint or even no NOS1 expression (Fig. 7). As al-
ready described in other tissues such as lung [33, 34],
smooth muscle cells and endothelial cells of blood vessels
expressed soluble guanylyl cyclase, and served as an in-
ternal positive control.
DISCUSSION
Although the effects of nitric oxide on kidney func-
tions have been extensively studied by using nitric oxide
donors and NOS inhibitors, it is unknown yet whether
nitric oxide, that is physiologically important for tubule
function, is endogenously produced by tubular epithelial
cells. Using several complementary approaches allowing
Fig. 5. Quantitative analysis of nitric oxide synthase (NOS1) mRNA to correlate the pattern of enzymatic activity with thelevels in normal human renal parenchyma. Total RNAs were extracted
from the cortex and the inner medulla of three normal human kidneys immunolocalization of the different NOS isoforms, the
(0, M, and W). Five micrograms of each RNA preparation were reverse present work demonstrates that, besides the expected
transcribed and submitted to real-time polymerase chain reaction (PCR)
NOS3 expressing endothelial cells, the epithelial cells ofusing a Light Cycler apparatus, as described in the Methods section.
Amounts of NOS1 amplification product were normalized to glyceralde- most tubules along the human nephron constitutively
hyde-3-phosphate dehydrogenase (GAPDH). In the three kidneys expressed a functional NOS1 with a corticomedullary
tested, a higher amount of NOS1 mRNA was observed in the cortex
gradient observed both at the protein and mRNA levels.than in the inner medulla.
Evidence for the presence of NOS activity in tubular
cells was first provided by examination of NADPH-dia-
fractions, respectively, suggesting the existence of other phorase activity on parenchyma sections. There is now
metabolic pathways capable of metabolizing arginine consensus that paraformaldehyde-resistant NADPH-dia-
into citrulline. The fact that NADPH-, NAME- or SMTC- phorase activity reflects NOS reductase activity [26]. In
dependent NOS activity was abrogated by the Ca- the only previous study using this methodology on paren-
chelator EGTA indicates the absence of NOS2 in the chyma sections of human kidney, Bachmann, Bosse, and
cortex and medulla. In addition, Figure 6 shows a cortex/ Mundel [23] found that NOS activity was restricted to
inner medulla gradient of NOS activity in the cytosolic cells of the macula densa during the first minutes of in-
fraction, parallell to the gradient of NOS1 expression cubation (5 to 10 minutes). Activity extended to endothe-
observed by immunoblot analysis. This gradient of activ- lial cells and to epithelial cells of proximal and distal tu-
ity was not observed in the pellet fraction, which reflects
bules only after long periods of incubation (up to 1 hour).
both NOS3 and membrane-bound NOS1 activities.
Although there is no evidence for loss of specificity with
time, the tubular and endothelial NOS activities were con-Immunolocalization of soluble guanylyl cyclase, a
sidered by the authors as a nonspecific signal. In our study,target of nitric oxide
this possibility can be ruled out since NADPH-diaphoraseOur finding that renal epithelial cells express a func-
was evident as early as after 5 minutes of incubation in thetional NOS strongly suggests that tubules must be an
endothelial cells, macula densa cells and tubular epithe-important source of nitric oxide. As soluble guanylyl
lial cells of most of the nephron segments. As shown bycyclase is often referred to as the physiologic nitric oxide
the use of several specific antibodies directed to the C- ortarget, we next determined the immunolocalization of
N-terminus part of NOS isoforms, NADPH-diaphorasesoluble guanylyl cyclase using a polyclonal anti-soluble
was due to NOS1 in macula densa and tubular epithelialguanylyl cyclase antibody. Soluble guanylyl cyclase was
cells, and to NOS3 in endothelial cells. These results arefound to be highly expressed in the various cell types of
consistent with previous work demonstrating that, in theboth cortex and medulla. In the cortex, tubular epithelial
kidney, the expression of NOS3 is restricted to vascularcells, which expressed NOS1 were also found to express
network [8, 23] and that NOS1 is expressed in the maculasoluble guanylyl cyclase, with a stronger staining in the
densa of many species including human [8, 23, 35]. In ad-proximal tubules (Fig. 4 and Table 2). When visible,
dition, a main finding of our study is the evidence of amacula densa expressed soluble guanylyl cyclase. In glo-
NOS1 expression in tubular epithelial cells, responsi-meruli, soluble guanylyl cyclase antibody labeled most
ble for their NADPH-diaphorase activity. Altogether,podocytes and some of the parietal cells, but not mesan-
our results obtained using histochemistry, immunohisto-gial cells (Table 2). The various tubules of the outer and
inner medulla also expressed soluble guanylyl cyclase, chemistry, immunoblot, and quantitative RT-PCR analy-
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Fig. 6. Measurement of nitric oxide synthase
(NOS) activity in the cytosol and pellet frac-
tions of cortex and inner medulla of human
normal kidney. Conversion of l-[14C]-arginine
into l-[14C]-citrulline was determined as de-
scribed in the Methods section. Results are ex-
pressed as picomole/milligram protein/minute
(pmol/mg/min). Lane 1 is the total l-[14C]-citrul-
line formation measured in the absence of
inhibitors; lane 2 is the nicotinamide adenine
dinucleotide phosphate (NADPH)-depen-
dent l-[14C]-citrulline formation; lane 3 is the
l-arginine analog N-nitro-l-arginine methyl
ester (L-NAME)-dependent l-[14C]-citrul-
line formation; lane 4 is the SMTC-depen-
dent l-[14C]-citrulline formation; lane 5 is the
ethyleneglycol tetraacetate (EGTA)-depen-
dent l-[14C]-citrulline formation; and lane 6
is the NG-monomethyl-l-arginine (L-NMMA)-
dependent l-[14C]-citrulline formation.
sis strongly suggest a cortex-inner medulla gradient of Henle were negative. Using RT-PCR on RNA prepared
from microdissected rat nephron segments, Terada et alNOS1 expression.
Finally, the existence of a constitutive NOS activity was [41] found NOS1 mRNA in inner medullary thin limb
and all along the collecting duct. So far the only tubulardemonstrated by measuring the conversion of l-[14C]-argi-
nine to l-[14C]-citrulline. In fact, our results showed a spe- structure where immunoreactive NOS1 was detected is
cortical collecting duct isolated from rats fed with highcific NOS activity in human kidney homogeneates, de-
spite the presence of other metabolic pathways leading K diet [42]. However, even in this case, the cellular lo-
cation of NOS1 appears different from that observed into citrulline [29, 36, 37]. These results are in agreement
with previous reports on NOS activity in human and rat the present study. Indeed, immunoreactivity was primar-
ily concentrated in cells with morphologic characteristicskidney [8, 17, 24, 25, 38]. Furthermore, in the samples
we studied, a constitutive Ca/calmodulin-dependent of principal cells, whereas intercalated cells displayed
weak labeling [42]. The reasons for the discrepancies inNOS activity was detectable in the cytosolic fraction,
reflecting NOS1 activity, with a cortex-inner medullar NOS expression between human and rat remain to be
established.gradient.
The situation in human kidney appears strikingly dif- Nitric oxide has been shown to act through a variety
of mechanisms, but most of its effects are mediated byferent from that in rat in several respects. In this species,
NADPH-dependent diaphorase activity [39] or Ca- a second messager cascade involving the generation of
cyclic guanosine monophosphate (cGMP) by soluble gu-dependent NOS activity [40] was indeed found several-
fold higher in inner medullary than in the cortex. An- anylyl cyclase [43]. Given also that, with the exception
of the inhibition of basolateral K channels in the ratother major divergence is that epithelial cells were found
positive for NOS1 in almost all the segments of the hu- cortical collecting duct, which results from an interaction
of nitric oxide with superoxide [44], all the tubular effectsman nephrons. Expression of NOS1 was particularly in-
tense in epithelial cells lining proximal tubules and thick of nitric oxide have been primarily ascribed to elevation
of cGMP [13, 45, 46], we investigated the immunolocali-ascendant limbs. Distal tubules and collecting ducts dis-
played heterogenous staining, whereas thin limbs of zation of soluble guanylyl cyclase. Soluble guanylyl cy-
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guanylyl cyclase in endothelial cells, indicating that both
epithelial and endothelial cells possess all the enzymatic
machinery necessary for an autocrine/paracrine action of
nitric oxide in human kidney. However, soluble guanylyl
cyclase is expressed in some cells which do not express
NOS1 such as tubular cells of the thin limb of Henle’s
loop, indicating that these cells can be submitted to a
paracrine action of exogeneous nitric oxide originating,
for example, from endothelial cells. Additional studies
will be necessary to determine the physiologic role of
NOS1 in epithelial cells and to establish whether its activ-
ity is regulated. Regarding these points, it is noteworthy
that inhibition of NOS1 expression by medullar intersti-
tial infusion of antisense oligonucleotide results in hyper-
tension [47] and that inhibitory effect of 2-adrenoceptor
on Cl transport are, in isolated thick ascending limbs,
mediated by nitric oxide [48].
CONCLUSION
The effects of nitric oxide on kidney function were
so far mainly explained by the expression of NOS in
endothelial cells and in the juxtaglomerular apparatus.
Our demonstration that NOS1 is strongly expressed in
epithelial cells of human normal kidney invites to recon-
sider this scheme as it may bring new insights in the
understanding of the tubular effects of nitric oxide on
electrolyte transport. In view of the fact that a recent
genetic analysis points to the role of NOS1 in chronic
renal failure, it is becoming clear that NOS1, in addition
to being a player in physiology, might be important in
the pathophysiology of renal disease [49].
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